Author Topic: Upcoming AAN conference to feature Ocrevus studies sponsored by Genentech  (Read 121 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9840
  • MS diagnosed 1980
  • Location: Pacific Northwest
It looks as if Genentech will be presenting quite a number of papers showing the efficacy and safety of Ocrevus at the annual AAN conference that will take place this month. There are a number of other new drugs on the list of presentations too.


https://www.businesswire.com/news/home/20180415005139/en/Genentech-Present-New-Data-AAN-Highlighting-Extensive
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
191 Views
Last post October 29, 2016, 07:30:09 am
by agate
0 Replies
179 Views
Last post March 04, 2018, 07:36:25 am
by agate
0 Replies
154 Views
Last post June 14, 2018, 11:10:36 am
by agate
0 Replies
50 Views
Last post April 14, 2021, 08:42:40 pm
by agate
2 Replies
27 Views
Last post April 05, 2024, 09:55:21 pm
by agate